Literature DB >> 28012718

Skin-Resident Effector Memory CD8+CD28- T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis.

Gang Li1, Adriana T Larregina2, Robyn T Domsic3, Donna B Stolz4, Thomas A Medsger3, Robert Lafyatis3, Patrizia Fuschiotti5.   

Abstract

Loss of CD28 expression by CD8+ T cells occurs with age and during chronic inflammatory conditions. CD8+CD28- T cells are a heterogeneous cell subpopulation whose function ranges from immunosuppressive to effector. Here we analyzed the role of CD8+CD28- T cells in the pathogenesis of systemic sclerosis (SSc), a connective tissue disorder characterized by autoimmunity, vasculopathy, and extensive cutaneous and visceral fibrosis. We show that the frequency of CD8+CD28- T cells is increased in the blood and affected skin of SSc patients, independent of patient age, and correlates with the extent of skin fibrosis. We found that most skin-tropic CD8+CD28- T cells are resident in the skin lesions of patients in the early stage of the disease, exhibit an effector memory phenotype, and present a strong cytolytic activity ex vivo. Skin-resident and circulating SSc CD8+CD28- T cells produce high levels of the profibrotic cytokine IL-13, which induces collagen production by normal and SSc dermal fibroblasts. Thus, our findings indicate that CD8+CD28- T cells represent a pathogenic T-cell subset in SSc and likely play a critical role in the early stage of SSc skin disease.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28012718      PMCID: PMC5433864          DOI: 10.1016/j.jid.2016.11.037

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  47 in total

1.  Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity.

Authors:  L Casciola-Rosen; F Andrade; D Ulanet; W B Wong; A Rosen
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

2.  GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production.

Authors:  Thomas A Medsger; Dana E Ivanco; Lela Kardava; Penelope A Morel; Mary R Lucas; Patrizia Fuschiotti
Journal:  Arthritis Rheum       Date:  2011-06

3.  Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera.

Authors:  M B Kahaleh; P S Fan
Journal:  Clin Immunol Immunopathol       Date:  1997-04

Review 4.  Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly.

Authors:  Sameem Abedin; Joshua J Michel; Bonnie Lemster; Abbe N Vallejo
Journal:  Exp Gerontol       Date:  2005-07       Impact factor: 4.032

5.  Numerical defects in CD8+CD28- T-suppressor lymphocyte population in patients with type 1 diabetes mellitus and multiple sclerosis.

Authors:  Zuzana Mikulkova; Petra Praksova; Pavel Stourac; Josef Bednarik; Lucie Strajtova; Rita Pacasova; Jana Belobradkova; Petr Dite; Jaroslav Michalek
Journal:  Cell Immunol       Date:  2010-02-06       Impact factor: 4.868

6.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Authors:  Patrizia Fuschiotti; Adriana T Larregina; Johnan Ho; Carol Feghali-Bostwick; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2013-01

7.  Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.

Authors:  Patrizia Fuschiotti; Thomas A Medsger; Penelope A Morel
Journal:  Arthritis Rheum       Date:  2009-04

8.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

9.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

10.  A skin-selective homing mechanism for human immune surveillance T cells.

Authors:  Patrick Schaerli; Lisa Ebert; Katharina Willimann; Andrea Blaser; Regula Stuber Roos; Pius Loetscher; Bernhard Moser
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  28 in total

1.  Setting Sights on Chlamydia Immunity's Central Paradigm: Can We Hit a Moving Target?

Authors:  Rodolfo D Vicetti Miguel; Nirk E Quispe Calla; Thomas L Cherpes
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

Review 2.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

Review 3.  Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.

Authors:  Benjamin Korman
Journal:  Transl Res       Date:  2019-02-23       Impact factor: 7.012

Review 4.  Phenotypic and Immunometabolic Aspects on Stem Cell Memory and Resident Memory CD8+ T Cells.

Authors:  Marco Pio La Manna; Mojtaba Shekarkar Azgomi; Bartolo Tamburini; Giusto Davide Badami; Leila Mohammadnezhad; Francesco Dieli; Nadia Caccamo
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.

Authors:  Aimee L Hanson; Joanne Sahhar; Gene-Siew Ngian; Janet Roddy; Jennifer Walker; Wendy Stevens; Mandana Nikpour; Shervin Assassi; Susanna Proudman; Maureen D Mayes; Tony J Kenna; Matthew A Brown
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

6.  14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in TC2 and CD8+ lymphocytes from patients with scleroderma.

Authors:  Sandra Cascio; Thomas A Medsger; William F Hawse; Simon C Watkins; Christine Milcarek; Larry W Moreland; Robert A Lafyatis; Patrizia Fuschiotti
Journal:  J Allergy Clin Immunol       Date:  2017-11-15       Impact factor: 10.793

Review 7.  Current perspectives on the role of CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Lett       Date:  2017-10-05       Impact factor: 3.685

Review 8.  Fibroblasts: Origins, definitions, and functions in health and disease.

Authors:  Maksim V Plikus; Xiaojie Wang; Sarthak Sinha; Elvira Forte; Sean M Thompson; Erica L Herzog; Ryan R Driskell; Nadia Rosenthal; Jeff Biernaskie; Valerie Horsley
Journal:  Cell       Date:  2021-07-22       Impact factor: 66.850

9.  Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.

Authors:  Katrin G Schmidt; Martina Herrero San Juan; Sandra Trautmann; Lucija Berninger; Anja Schwiebs; Florian M Ottenlinger; Dominique Thomas; Frank Zaucke; Josef M Pfeilschifter; Heinfried H Radeke
Journal:  Front Immunol       Date:  2017-09-29       Impact factor: 7.561

Review 10.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.